Bader, Ted, M.D.
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Bader, Ted, M.D. sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Bader, Ted, M.D.: 6 sponsored US clinical trials, none currently recruiting.
Bader, Ted, M.D. sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 0 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Chronic Hepatitis C, with 1 trials.
Upper-quartile sponsor footprint
Bader, Ted, M.D. sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
6 total, page 1 of 1
HCV Treatment With Fluvastatin, Simvastatin to Improve Interferon Sensitivity
NCT01377909
Simvastatin for the Treatment of Chronic Hepatitis B
NCT00994773
Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy
NCT00749138
Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin
NCT00487318
Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C
NCT00446940
Fluvastatin Versus Hepatitis C Virus
NCT00441493
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 2 |
Therapeutic Areas
How the Bader, Ted, M.D. early-phase archive is shaped
6 indexed studies, none listed as recruiting (0% open); 5 completed (83%).
Phase mix: 0 late (III/IV) vs 5 early (I/II) (early-phase heavy).
Top condition: Chronic Hepatitis C (1 trial), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Bader, Ted, M.D.: archived-pipeline peers nationwide
Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Bader, Ted, M.D. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 archived trials
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
Related
What to do with this Bader, Ted, M.D. page
6 registered trials is a research-attention snapshot, not an endorsement of Bader, Ted, M.D. or any single study.
- None of Bader, Ted, M.D.'s trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Chronic Hepatitis C is the condition Bader, Ted, M.D. studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Hepatitis C trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Bader, Ted, M.D. pipeline card: 6 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.